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Abstract
The proportion of infant pertussis cases due to transmission from casual contact in the community
has not been estimated since before the introduction of pertussis vaccines in the 1950s. This study
aimed to estimate the proportion of pertussis transmission due to casual contact using
demographic and clinical data from a study of 95 infant pertussis cases and their close contacts
enrolled at 14 hospitals in France, Germany, Canada, and the U.S. between February 2003 and
September 2004. A complete case analysis was conducted as well as multiple imputation (MI) to
account for missing data for participants and close contacts who did not participate. By considering
all possible close contacts, the MI analysis estimated 66% of source cases were close contacts,
implying the minimum attributable proportion of infant cases due to transmission from casual
contact with community members was 34% (95% CI = 24%, 44%). Estimates from the complete
case analysis were comparable but less precise. Results were sensitive to changes in the operational
definition of a source case, which broadened the range of MI point estimates of transmission from
casual community contact to 20%–47%. We conclude that casual contact appears to be responsible
for a substantial proportion of pertussis transmission to young infants.
Medical subject headings (MeSH): multiple imputation, pertussis, transmission, casual contact,
sensitivity analysis, missing data, community.
Introduction
Pertussis disease is poorly controlled among infants, ado-
lescents, and adults in developed countries despite high
immunization coverage rates [1-3] of ≥ 93 percent for
both the primary infant series [4-6] and the booster at
school entry [7]. Bordetella pertussis is reported to be
among the most contagious pathogens in humans as an
average of 15 secondary infections arise from a single case
in a susceptible population [8]. Public health messages
focus on the importance of transmission from close con-
tacts [9-11] implying that pertussis transmission due to
casual contact from community members is not apprecia-
ble.
Several studies investigated the disease dynamics of B. per-
tussis, especially as they relate to the transmission of the
bacteria to young infants. This has been done by collect-
ing diagnostic information on close contacts and assign-
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source of infection (where the difficulty in identifying the
source case usually lies in identifying even one sympto-
matic source case as opposed to choosing from multiple
potential cases). These studies identified close/household
contacts as a source of infection for 40–53 percent of
young infants with pertussis [12-16]. However, none of
these studies investigated whether the remaining 47–60
percent of transmission was due to casual contact in the
community or caused by transmission from unidentified
close contacts as no attempt was made to rule out trans-
mission from all identifiable household and other close
contacts.
In order to infer transmission from a casual contact
source, it is necessary to conclusively determine transmis-
sion did not occur from a close contact source. Several
obstacles have hindered previous studies' ability to elimi-
nate the possibility that transmission came from a close
contact source. First, missing data due to non-participa-
tion of close contacts and participants' refusal to provide
specimens for laboratory diagnostic testing has been high
[12] or unreported, limiting the ability to determine
whether a given contact would have been identified as the
source of the index case's infection had the data not been
missing. Second, diagnosing pertussis is often problem-
atic since many adolescent and adult pertussis cases do
not present with the typical symptoms of whooping
cough [17-19]. This is further complicated by the lack of a
highly sensitive and specific laboratory diagnostic method
[10,20]. Third, inter-person variability in the incubation
and infectious periods [21,22] may result in failure to
identify source cases if their incubation or infectious peri-
ods lie in the tails of the distributions not captured by
standard definitions [16,23-25]. Finally, it is uncertain
whether individuals with asymptomatic infection can
transmit pertussis [13,26,27]. In the absence of sound evi-
dence for or against the infectiousness of asymptomatic
infections, the systematic exclusion of asymptomatically
infected individuals as possible source cases (as done in
all previous studies) may bias the results.
In this paper we estimated the minimum proportion of
infant pertussis cases due to transmission from casual
contact sources using information from a study designed
to identify the source of infection in young infants. Results
from multiple diagnostic tests (including polymerase
chain reaction [PCR], culture, and paired serology) were
available on household contacts and non-household per-
sons with close contact with the infant. To adjust for miss-
ing data arising from non-enrollment or failure to provide
diagnostic specimens, multiple imputation (MI) analysis
was used. MI is a widely accepted method to account for
missing data and is superior to complete case analyses for
two reasons.
First, as the amount of missing data increases, the results
from complete case analyses suffer a greater loss in preci-
sion than results obtained by MI analyses [28,29]. Second,
when data are not missing completely at random (MCAR)
and the missing data mechanism is appropriately speci-
fied, MI will produce less biased estimates than a com-
plete case analysis to the extent that missingness is
associated with the observed data [28,30]. This is particu-
larly germane to this pertussis study since missingness is
likely dependent on relationship to the index case. In
addition to MI, sensitivity analyses were conducted to
determine the effect of varying the sensitivity and specifi-
city of the source case definition, including an analysis




Study design, participants, and data collection
A prospective multi-center epidemiologic study was con-
ducted from February 3, 2003 through September 15,
2004 in 14 hospitals in four countries: Canada, France,
Germany, and the U.S. [31]. Approval from Institutional
Review Boards was obtained at each participating site and
written informed consent was obtained from each partic-
ipant. Partially vaccinated and unvaccinated infants aged
≤ six months diagnosed with laboratory confirmed pertus-
sis (by PCR or culture) were invited to participate. Upon
enrollment of the infant index case, all household mem-
bers and eligible non-household contacts were recruited.
Non-household contacts were eligible if they were in con-
tact with the infant during the month prior to symptom
onset in the index case and were either: 1) a full-time care-
taker (> 30 hours/week) of the infant index case or 2) had
an acute cough illness lasting at least seven days in the
month prior to the pertussis diagnosis in the index case.
Demographic and clinical information relevant to pertus-
sis was collected on each index case. During the interview
with the parent of the index case, information was col-
lected on all household members and eligible non-house-
hold contacts, independent of their participation in the
study. Information collected pertained to the contacts'
relationship and amount of contact with the index case,
and the presence and duration of symptoms of cold or
cough in the contact during the month prior to enroll-
ment of the index case. All contacts of the index case were
also invited to be interviewed face-to-face using a standard
questionnaire to obtain relevant demographic and clini-
cal data.
All participants were asked to provide a sample collected
via nasopharyngeal aspirate or swab for culture and PCR
detection of B. pertussis and an acute blood sample for
immunoglobulin-G (IgG) anti-pertussis toxin antibodyPage 2 of 7
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assay (ELISA). One month later, data on the presence of
cough and cold-like symptoms and a convalescent blood
sample were collected from participating contacts.
All PCR and serum samples were sent to the Reference
Laboratory for Whooping Cough and other Bordetelloses
Institut Pasteur in Paris. Nasopharyngeal specimens were
analyzed with real-time PCR using the IS481 target and
measurement of anti-PT IgG, using ELISA, were performed
according to recent recommendations[32].
Case definitions
Source cases were either laboratory confirmed or epidemi-
ologically linked pertussis cases with onset of cough two
to 48 days prior to symptom onset in the infant index case
[9,22]. When two or more contacts reported symptoms
prior to the index case, the person with the earliest symp-
tom onset (within the defined time-frame) was assigned
as the source case. Multiple source cases were allowed if
their symptom onset was reported to be the same day.
Laboratory confirmation was defined by at least one of the
following: positive culture, positive PCR, a ≥ four-fold
change [33] in IgG titer to anti-PT between acute and con-
valescent serum samples, or a single anti-PT IgG antibody
titer ≥ 125 EU/mL [34,35]. For immunized children aged
three months to three years and four to seven years, anti-
PT titer results were not used for confirmation of pertussis
as they may be influenced by recent vaccination. Epidemi-
ologically linked cases were defined as persons in contact
with the infant index case in the month preceding symp-
tom onset in the index case, who had an acute cough ill-
ness lasting ≥ two weeks, but no laboratory confirmation
of pertussis [36]. Laboratory confirmed asymptomatic
cases of pertussis were also identified. They met the same
criteria as laboratory confirmed symptomatic cases, but
did not report any cough or cold symptoms.
Primary outcome analysis
The proportions of infant pertussis cases infected by close
contacts and casual contacts were estimated using com-
plete case and multiple imputation analyses. 95 percent
confidence intervals were calculated in Stata 8.2 (College
Station, TX) for the complete case analysis and in Excel
2002 for the MI analysis [37]. Generalized estimating
equations (GEE) regression using an exchangeable work-
ing correlation matrix was used for the MI models to allow
possible clustering within households. GEE regression
models were fit using SAS 9.3.1 (Cary, NC).
The complete case analysis included all index cases for
whom (1) complete enrollment of all eligible close con-
tacts (household and non-household) was achieved and
(2) all enrolled contacts had complete diagnostic data,
defined as information on symptoms, results from PCR,
and results from at least one serum sample.
GEE regression models were fit to build predictive models
for MI. As the demographic and symptom history data
(including age, relationship to the index case, amount of
contact with the index case, household size, presence of
cold/cough symptoms, presence of cough lasting at least
two weeks, and continent of birth) were available on all
identified close contacts, independent of study participa-
tion, missing data from non-participants were treated the
same as missing data from participants. This information
was used as predictor variables in building the imputation
model. The imputation model predicted the probability
that each symptomatic contact with missing data was the
source case for the index case. We created 10 imputed data
sets, adapting the methods described by Raghunathan et
al. [30] for non-sequential logistic regression. Indicator
variables incorporating interactions between three
explanatory variables (relationship to the index case,
severity of symptoms, and amount of contact with the
infant) were generated. For example, one variable indi-
cated all parents with a cough lasting ≥ two weeks and
contact with the index case for > five hours/day; another
indicated all siblings with a cough lasting ≥ two weeks and
contact with the index case for > five hours/day. House-
hold size (a count variable) was also included in the pre-
dictive model. The average number of source cases from
the 10 imputed data sets was used as the estimated
number of source cases. Approximate 95% CIs were calcu-
lated using a standard normal approximation and the
multiple imputation variance estimate [28,30].
The missing data mechanism was assumed to be ignora-
ble. An ignorable missing data mechanism in this study
means that missingness (i.e., inability to make a pertussis
diagnosis due to non-enrollment or failure to provide
diagnostic specimens) was independent of being a source
case, conditional on the observed data (i.e., age, relation-
ship to the index case, amount of contact with the index
case, household size, presence of cold/cough symptoms,
and presence of cough lasting at least two weeks).
Sensitivity analyses
Sensitivity analyses were conducted on the multiply
imputed data to assess the impact of the sensitivity and
specificity of the source case definition. In the specific
source case definition analysis, specificity was increased by
requiring symptom onset in the source case to occur seven
to 30 days prior to symptom onset in the index case [23-
25,38,39]. In the sensitive source case definition analysis,
sensitivity was increased by allowing individuals with lab-
oratory confirmed asymptomatic pertussis to be source
cases when no other source case could be identified for an
infant index case. In the latter analysis, the outcome valuePage 3 of 7
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contacts with missing data, independent of symptoms.
Analysis of infant characteristics associated with transmission from a 
casual contact source
Risk ratios (RR) and 95 percent confidence intervals (CI)
were calculated to identify risk factors for pertussis in
infants as a result of B. pertussis transmission by casual
community contact. Potential risk factors included age,
sex, time from symptom onset to diagnosis, vaccination
status, hospitalization status, household size, location of
child care, presence of an adolescent close contact, enroll-
ment of at least one non-household close contact, and
continent of residence. Data from each imputed data set
were used to fit modified Poisson regression models
(which uses a robust error variance) to estimate the log
binomial model [40]. (Modified Poisson regression was
used to overcome non-convergence problems using bino-
mial regression.) Crude RR estimates were computed by
averaging the corresponding estimates from the 10 fitted
models with each potential risk factor as the lone covari-
ate. Fully adjusted RR estimates were computed similarly
based on models including each of the above characteris-
tics of the infant index cases. Approximate 95% CIs were
calculated using standard normal approximations and
multiple imputation variance estimates. The fully
adjusted model included each of the above characteristics




The study population comprised 95 infant index cases
and 460 identified eligible close contacts. A pair of twins
were enrolled with identical onset dates and contact pat-
terns and thus treated as a single case, leaving a total of 94
cases. Fifty-six contacts refused enrollment. Complete
enrollment (i.e., enrollment of all household and eligible
non-household close contacts) was achieved for 70 index
cases and their 316 contacts. Outcome (case) status was
missing for 51 (12.6%) of the 404 participating contacts:
21 symptomatic and 30 asymptomatic participating con-
tacts (Table 1). Complete information (i.e., complete
enrollment and complete laboratory data) was available
for 45 index cases and their 193 contacts.
The distribution of all identified close contacts to the
infant index cases, stratified by household contact type
(adult household, child household and non-household
status) and enrollment status is shown in Table 1. Among
study participants, child household contacts and non-
household contacts were more likely than adult house-
hold contacts to be missing outcome status: odds ratio
(OR) = 9.2 (95 percent CI = 3.9, 21.6) and OR= 6.4 (95
percent CI = 2.4, 16.7), respectively. Age (OR = 1.0, 95
percent CI = 0.98, 1.01), symptoms before the first visit
(OR = 0.7, 95 percent CI = 0.4, 1.2), and level of contact
with the infant (OR = 1.0, 95 percent CI = 1.0, 1.1) were
not associated with missing outcome status. However,
relationship with the infant index case was associated
with non-participation as siblings (OR = 2.5, 95 percent
CI = 1.1, 5.4) and "other" contacts (OR = 3.3, 95 percent
CI = 1.6, 7.0) were less likely than parents to enroll. Thus,
the data were not MCAR among both participants and
non-participants.
Complete case and multiple imputation analyses
A source case could not be identified among the close con-
tacts for approximately one in three infants with pertussis.
Even though the MI analysis identified on average eight
additional source cases, the estimates on the proportion
of infants for whom no source case could be identified
were similar between the MI (34 percent, 95 percent CI =
24 percent, 44 percent) and complete case analyses (31
percent, 95 percent CI = 17 percent, 45 percent), with the
estimate from the MI analysis being slightly more precise
(Table 2). Assuming missingness among participants was
missing at random and no misclassification of outcome
status occurred, it can be inferred that infants for whom
no close contact source case was identified were infected
through casual contact with an infectious case of pertussis
in the community. Multiple source cases were identified
for four index cases.
Sensitivity analyses
In the specific source case definition analysis, using the more
restrictive period of incubation and infectiousness (seven
to 30 days instead of two to 48 days), a source case was
identified using MI for an average of 50 (53 percent) index
cases, implying that casual contact in the community was
solely responsible for 47 percent (95 percent CI = 36 per-
cent, 58 percent) of transmission to young infants (Table
2). In the sensitive source case definition analysis, allowing
laboratory confirmed asymptomatically infected persons
to be source cases, a source case was identified using MI
for an average of 75 (80 percent) infants, implying the
remaining 20 percent (95 percent CI = 10 percent, 30 per-
cent) of index cases were infected by casual contact in the
community (Table 2).
Predictors of transmission from the community
Risk ratios (95 percent confidence intervals) for character-
istics of the index cases associated with an unidentified
source of transmission, implying transmission from cas-
ual contact in the community, are presented in Table 3.
Time from symptom onset to diagnosis, childcare outside
the home, and household size were factors we a priori
thought might be associated with community transmis-
sion. No strong associations were identified between
infant characteristics and having a casual contact as thePage 4 of 7
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null value and bounded by relatively wide confidence
intervals. The strongest association observed was infants
born in North America had a greater risk of having a
source case being a casual contact than infants born in
Europe (RR = 3.29; 95 percent CI = 0.86, 12.7). It is inter-
esting to note the reversal of the estimated effect of being
partially vaccinated in the crude and fully adjusted mod-
els. No single characteristic was identified as a confounder
for this observation.
Conclusion
In this study, we estimated the proportion of pertussis
transmission to young infants due to casual contact with
community members. We estimate that approximately
one in three infants with pertussis is infected though cas-
ual contact with a source case in the community.
By collecting some data on all non-enrolled eligible close
contacts (during the first interview with the parents of the
infant index case) we employed an imputation model
which accounted for missing data and thus utilized
observed data from all 460 identified close contacts of the
94 index cases. Assuming that data were missing at ran-
dom and that there was no misclassification of the out-
come status when using PCR and serological diagnostic
methods, we inferred that in the absence of identifying a
source case among close contacts of the index infant cases,
pertussis transmission to these young infants was due to
casual contact in the community.
The only other study to estimate the proportion of casual
or community transmission was performed in the pre-vac-
cine era. In 1913–1914, Luttinger followed 2,310 pertus-
sis cases who attended a whooping cough clinic [41]. The
sources of infection, as reported by the guardian, were
identified close contacts such as neighbor (56.8 percent),
relative or friend (17.6 percent), school or nursery (9.6
percent), causal contact at movies, recreation pier, roof
gardens, ferry, street, and public transportation (4.6 per-
cent); and unknown (11.4 percent) [41]. Considering the
dramatic change that widespread vaccination wrought on
the epidemiology and disease dynamics of pertussis [42],
the comparison of results is somewhat trivial. One expla-
nation for the observed increase in the proportion of
transmission due to casual contact in the vaccine era is
that widespread vaccination reduces the severity of symp-
toms, allowing those infected with B. pertussis to continue
their daily activities, thus shifting a greater proportion of
transmission from the home to the community. It is also
possible some close non-household contacts were not
identified in this study as a result of asymptomatic and
atypical, mild presentation of pertussis in vaccinated indi-
viduals [43].
Table 1: Distribution of all identified close contacts to infant index cases, stratified by enrollment status, information on outcome 
(case) status, presence of symptoms, and household contact type.
Adult Household Child Household Non-household Total
n % n % n % n %
Enrolled, known outcome (case) status 199 84.3 96 63.6 58 79.5 353 76.7
Enrolled, missing outcome status 7 3.0 31 20.5 13 17.8 51 11.1
Symptomatic 1 0.4 14 9.3 6 8.2 21 4.6
Asymptomatic* 6 2.6 17 11.2 7 9.6 30 6.5
Not enrolled 30 12.7 24 15.9 2 2.7 56 12.2
Symptomatic 11 4.7 12 7.9 2 2.7 25 5.4
Asymptomatic 19 8.1 12 7.9 0 0.0 31 6.7
Identified contacts 236 100.0 151 100.0 73 100.0 460 100.0
*Multiple imputation was not used to impute source case status among asymptomatic persons in the main analysis (and the specific case definition 
analysis), because they are, by definition, not a source case in these analysis.
Table 2: Proportion of infants for whom a close contact source case was identified versus for whom a community contact source was 
inferred stratified by analysis type.
Analysis Infants included 
in analysis
For whom a source case 
was identified
For whom contact in community likely responsible
n % n % 95%CI n % 95%CI
Complete Case 45 47.9 31 68.9 (55.4, 82.4) 14 31.1 (17.6, 44.6)
Primary Multiple Imputation 94 100.0 62 65.7 (55.7, 75.8) 32 34.2 (24.2, 44.3)
Specific Source Case Definition* 94 100.0 50 53.4 (42.3, 64.4) 44 46.6 (35.6, 57.6)
Sensitive Source Case Definition** 94 100.0 75 79.7 (69.8, 89.6) 19 20.3 (10.4, 30.2)
*The specific source case definition analysis requires symptom onset in primary cases to occur 7–30 days prior to symptom onset in the index case
**The sensitive source case definition allows asymptomatically infected persons to be primary cases in the absence of identifying a symptomatic 
primary casePage 5 of 7
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potentially be associated with the source of transmission,
we failed to identify factors significantly associated with
transmission due to casual contact from the community.
Similar to our results, a study in 1988 attempted to iden-
tify risk factors for community-acquired pertussis, and
found that exposure outside the household was the only
significant predictor [44].
Several limitations to the study are important to note.
First, we were unable to prove that the missing data mech-
anism was ignorable (i.e. was not dependent on source
case status). Second, the identification of individuals with
asymptomatic infections as the source case is limited by
the unknown chronology of infection as those with
asymptomatic infection could either have infected the
index case or have been infected by the index case. Fur-
thermore, transmission from asymptomatic infected indi-
viduals has not been conclusively demonstrated. In the
context of infant pertussis, transmission may not require
aerosol generation through coughing or sneezing as respi-
ratory secretions are likely to be shared through activities
such as kissing, cuddling, and singing. The finding that, in
the sensitive source case definition sensitivity analysis, a
source case was identified among close contacts for an
additional 14% of infants underscores the potential role
of these carriers in the transmission of B. pertussis to young
infants.
In conclusion, this study presents evidence that casual
contact from the community is responsible for 34 percent
of pertussis transmission to young infants (20–47 percent
including sensitivity analyses, and 10–60 percent includ-
ing confidence intervals from sensitivity analyses). This
proportion is higher than the 5–16 percent reported in the
pre-vaccine era and provides insight in the transmission
dynamics of B. pertussis beyond observations from prior
vaccine era studies where no source case could be identi-
fied for 47–60 percent of infant index cases [12-16]. Our
results indicate that in future efforts to control pertussis in
infants, transmission from both close and casual commu-
nity contacts may need to be addressed. The cocoon vacci-
nation strategy [45] and the routine adolescent [1] and
adult vaccination strategies may thus be complementary
strategies in the control of infant pertussis.
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